Clinical trial
Thyroid Hormone Analog Therapy in MCT8 Deficiency: Triac Trial Patients
NCT02060474 · Erasmus Medical Center, Other · Completed
Key facts
| NCT number | NCT02060474 |
|---|---|
| Title | Thyroid Hormone Analog Therapy in MCT8 Deficiency: Triac Trial Patients |
| Official title | Thyroid Hormone Analog Therapy of Patients With Severe Psychomotor Retardation Caused by Mutations in the MCT8 Thyroid Hormone Transporter: The Triac Trial. |
| Lead sponsor | Erasmus Medical Center, Other |
| Collaborators | ZonMw: The Netherlands Organisation for Health Research and Development |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Allan-Herndon-Dudley Syndrome |
| Intervention type | Drug |
| Interventions | Triac |
| Enrollment | 46 |
| Start date | Oct 1, 2014 |
| Primary completion | Jun 26, 2018 |
| Completion | Jun 26, 2018 |
| First posted | Feb 12, 2014 |
| Last update posted | Apr 16, 2019 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: